首页> 外文期刊>藥學雜誌 >Findings from a Questionnaire Survey on New Guidelines for Preparing Drug Guide for Patients and a Perspective from a Pharmaceutical Company as the Information Provider
【24h】

Findings from a Questionnaire Survey on New Guidelines for Preparing Drug Guide for Patients and a Perspective from a Pharmaceutical Company as the Information Provider

机译:关于患者制备患者毒品指南的新准则调查调查的调查结果及来自制药公司作为信息提供者的透视

获取原文
获取原文并翻译 | 示例
           

摘要

Draft versions of two products of based on a "Drug Guide for Patients" have been prepared the guidelines proposed in "Research on risk communication between patients and healthcare professionals regarding information on safety measures for drugs, etc." by Health and Labour Sciences Research Grants. We conducted a questionnaire survey on the draft to identify issues regarding the contents and their preparation from the viewpoint of pharmaceutical companies as authors. The questionnaire results indicated that, the segments of the contents of the "Drug Guide for Patients" based on the new guidelines are generally acceptable. In this paper, the author offers proposals to address issues regarding the preparation of easy-to-read contents for patients and strategies to promote the overall understanding recognition of Drug Guide for Patients. Drug Guide for Patients are expected to be utilized as materials providing information to be used for routine risk minimization activities of the Risk Management Plan in the future.
机译:基于“患者药物指南”的两种产品草案已经准备了“患者与医疗保健专业人员之间有关药物安全措施的信息的风险沟通研究”的指导方针。通过健康和劳动科学研究补助金。我们对草案进行了调查问卷调查,以确定从制药公司作为作者的内容和编写的问题。问卷结果表明,基于新指南的“药物指南”的内容的分组通常是可接受的。本文提出了提案,以解决关于患者和策略易于阅读内容的关于促进患者药物指南的整体理解认可的问题。预计患者的药物指南将被用作提供用于未来风险管理计划的日常风险最小化活动的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号